Antimicrobial resistance in typhoidal salmonellae

Indian Journal of Medical Microbiology

Volumn 29, Issue 3, 2011, Pages 223-229

  Harish, B N ^a,b   Menezes, G A ^b  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b SREE BALAJI MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

cephalosporins; fluoroquinolone; quinolone resistance determining region; typhoidal salmonellae; lactamases

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CARBAPENEM; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PROTEIN PARC; PROTEIN PARE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; TYPHOID VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG USE; ENTEROBACTERIACEAE; EPIDEMIC; HAND WASHING; HUMAN; INDIA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; REVIEW; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TREATMENT DURATION; TYPHOID FEVER;

EID: 80052619815     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.83904     Document Type: Review

References (51)

1. Cooke FJ, Wain J. The emergence of antibiotic resistance in typhoid fever. Travel Med Infect Dis 2004;2:67-74. (Pubitemid 39022904)
2. Butt T, Ahmad RN, Mahmood A, Zaidi S. Ciprofloxacin treatment failure in typhoid fever case, Pakistan. Emerg Infect Dis 2003;9:1621-2. (Pubitemid 37505462)
3. Parry CM. Antimicrobial resistance in Salmonella enterica. Curr Opin Infect Dis 2003;16:467-72.
4. Harish BN, Menezes GA, Sarangapani K, Parija SC. A case report and review of the literature: Ciprofloxacin resistant Salmonella enterica serovar Typhi in India. J Infect Dev Ctries 2008;2:324-7.
5. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7 th Ed. Washington DC: ASM Press; 1999.
6. Brown JD, Duong Hong M, Rhoades ER. Chloramphenicol-resistant Salmonella typhi in Saigon. JAMA 1975;231:162-6.
7. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: A worldwide epidemic. Clin Infect Dis 1997;24 Suppl 1:S106-9.
8. Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med Hyg 2004;98:423-30. (Pubitemid 38950385)
9. Yu VL, Merigan TC Jr, Barriere SL, editors. Antimicrobial therapy and vaccines. Baltimore (Maryland): William and Wilkins; 1999.
10. Toro CS, Lobos SR, Calderon I, Rodriguez M, Mora GC. Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob Agents Chemother 1990;34:1715-9. (Pubitemid 20259499)
11. Pillai PK, Prakash K. Current status of drug resistance and phage types of Salmonella typhi in India. Indian J Med Res 1993;97:154-8. (Pubitemid 23294279)
12. Sheorey HS, Kaundinya DV, Hulyalkar VS, Deshpande AK. Multi drug resistant Salmonella typhi in Bombay. Indian J Pathol Microbiol 1993;36:8-12. (Pubitemid 23186530)
13. Nagshetty K, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries 2010;4:70-3.
14. Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res 2004;120:111-4. (Pubitemid 39248287)
15. Menezes GA, Harish BN, Khan MA, Goessens WH, Hays JP. Antimicrobial Resistance Trends in Blood Culture Positive Salmonella Typhi isolates from Pondicherry, India, 2005 - 2009. Clin Microbiol Infect 2011 Apr 25. doi: 10.1111/j.1469-0691.2011.03546.x. [Epub ahead of print]
16. Harish BN, Menezes GA. Preserving efficacy of chloramphenicol against typhoid fever in a tertiary care hospital, India. Regional Health Forum, WHO South-East Asia Region. 2011;15:92-6.
17. Liberti A, Loiacono L. Ciprofloxacin versus chloramphenicol in the treatment of salmonella infection. Int J Antimicrob Agents 2000;16:347-8.
18. Parry CM. The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 2004;98:413-22. (Pubitemid 38950384)
19. DuPont HL. Quinolones in Salmonella typhi infection. Drugs 1993;45 Suppl 3:119-24.
20. Chandel DS, Chaudhry R. Enteric fever treatment failures: A global concern. Emerg Infect Dis 2001;7:762-3. (Pubitemid 32845280)
21. Miller IS, Pegues DA. Salmonella species, including Salmonella Typhi. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennetts principles and practice of infecftious disease. 5th Ed. Philadelphia: Churchill Livingstone; 2000. p. 2344-63.
22. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003;37:75-81. (Pubitemid 36836648)
23. Allen KJ, Poppe C. Phenotypic and genotypic characterization of food animal isolates of Salmonella with reduced sensitivity to ciprofloxacin. Microb Drug Resist 2002;8:375-83. (Pubitemid 36043705)
24. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: A United States FoodNet multicenter retrospective cohort study. Antimicrob Agents Chemother 2008;52:1278-84. (Pubitemid 351521988)
25. Gay K, Robicsek A, Strahilevitz J, Park CH, Jacoby G, Barrett TJ, et al. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis 2006;43:297-304. (Pubitemid 44078900)
26. Xia S, Hendriksen RS, Xie Z, Huang L, Zhang J, Guo W, et al. Molecular characterization and antimicrobial susceptibility of Salmonella from infections in humans in Henan province, China. J Clin Microbiol 2009;47:401-9.
27. Keddy KH, Smith AM, Sooka A, Ismail H, Oliver S. Fluoroquinolone- Resistant Typhoid, South Africa. Emerg Infect Dis 2010;16:879-80.
28. Ruiz J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003;51:1109-17. (Pubitemid 36622067)
29. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis 2005;41(Suppl. 2):S120-6. (Pubitemid 40962482)
30. Adachi T, Sagara H, Hirose K, Watanabe H. Fluoroquinolone-resistant Salmonella Paratyphi A. Emerg Infect Dis 2005;11:172-4.
31. Saha SK, Darmstadt GL, Baqui AH, Crook DW, Islam MN, Islam M, et al. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh. J Clin Microbiol 2006;44:3811-3. (Pubitemid 46772904)
32. Dutta S, Sur D, Manna B, Sen B, Bhattacharya M, Bhattacharya SK, et al. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India. Int J Antimicrob Agents 2008;31:387-9.
33. Parry CM, Threlfall EJ. Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 2008;21:531-8.
34. Pfeifer Y, Matten J, Rabsch W. Salmonella enterica Serovar Typhi with CTX-M -Lactamase, Germany. Emerg Infect Dis 2009;15:1533-4.
35. Al Naiemi N, Zwart B, Rijnsburger MC, Roosendaal R, Debets-Ossenkopp YJ, Mulder JA, et al. Extended-Spectrum-Beta-Lactamase Production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol 2008;46:2794-5.
36. Rotimi VO, Jamal W, Pal T, Sovenned A, Albert MJ. Emergence of CTX-M-15 type extended-spectrum betaβ-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol 2008;57:881-6.
37. Gokul BN, Menezes GA, Harish BN. ACC-1 beta-Lactamase-producing Salmonella enterica Serovar Typhi, India. Emerg Infect Dis 2010;16:1170-1.
38. Engels EA, Falagas ME, Lau J, Bennish ML. Typhoid fever vaccines: A meta-analysis of studies on efficacy and toxicity. BMJ 1998;316:110-6. (Pubitemid 28121109)
39. Pandit A, Arjyal A, Day JN, Paudyal B, Dangol S, Zimmerman MD, et al. An open randomised comparison of gatifloxacin versus cefixim for the treatment of uncomplicated enteric fever. PLoS ONE 2007;2:e524.
40. Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008;4:CD006083.
41. Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS ONE 2008;3:e2188.
42. Pfeifer Y, Matten J, Rabsch W. Salmonella enterica Serovar Typhi with CTX-M -Lactamase, Germany. Emerg Infect Dis 2009;15:1533-4.
43. Raveendran R, Wattal C, Sharma A, Oberoi JK, Prasad KJ, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008;26:50-3. (Pubitemid 351197562)
44. Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007;101:308-10. (Pubitemid 46029794)
45. Capoor RM, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: Emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007;56:1131-2. (Pubitemid 47262683)
46. Renuka K, Sood S, Das BK, Kapil A. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 2005;54:999-1000. (Pubitemid 41395861)
47. Harish BN, Menezes GA, Sarangapani K, Parija SC. Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry. Indian J Med Res 2006;124:585-7.
48. Harish BN, Madhulika U, Parija SC. Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A. J Med Microbiol 2004;53(Pt 8):819. (Pubitemid 39430370)
49. Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, et al. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 2006;58:1139-44. (Pubitemid 44884131)
50. Mohanty S, Renuka K, Sood S, DAS BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006;134:961-6. (Pubitemid 44336370)
51. Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005;366:749-62. (Pubitemid 41207239)